Introduction {#s1}
============

Multiple levels of synaptic organization ensure accurate, controlled information flow through neuronal circuits. Neurons must first make an appropriate number of synaptic connections with their postsynaptic partners. Each of these synaptic connections must have appropriate strength that can be modified by plasticity and homeostasis as a result of experience and activity changes. Further, there must be an appropriate balance between excitatory and inhibitory synapses. Finally, recent work has shown that these connections also occupy precise locations with regards to the three-dimensional structure of the synaptic neuropil. Indeed, circuit models for diverse neuronal ensembles fail to recapitulate functional patterns unless these aspects are accounted for ([@bib40]; [@bib96]). The misregulation of any one of these organizational parameters can result in neurodevelopmental disorders and intellectual disabilities like autism ([@bib60]), epilepsy ([@bib9]), and other synaptopathies ([@bib29]). Revealing the molecular mechanisms that ensure all of these facets are achieved is a critical step in understanding circuit assembly and function.

Synaptic organizers like Neurexins / Neuroligins, Teneurins, protein tyrosine phosphatases (PTPs), leucine rich repeat transmembrane proteins (LRRTMs), and Ephrin / Eph receptors, among others, ensure the proper number, distribution, and function of synaptic connections ([@bib34]; [@bib59]; [@bib80]; [@bib85]; [@bib88]; [@bib19]). Loss-of-function mutations in these key synaptogenic molecules have deleterious structural, functional, and organizational consequences for synapses and circuits. At the vertebrate neuromuscular junction, one of these critical organizers is LRP4. There, it forms a receptor complex with MuSK in muscle fibers to promote clustering of acetylcholine receptors in response to motoneuron-derived agrin ([@bib107]; [@bib41]; [@bib100]). Muscle LRP4 can also function as a retrograde signal with an unknown motoneuron receptor to regulate presynaptic differentiation ([@bib106]). In these roles, the known functions from LRP4 are overwhelmingly postsynaptic. However, a number of lines of evidence suggest a broader role, beyond postsynaptic, for LRP4. First, motoneuron-derived LRP4 can regulate presynaptic differentiation, demonstrating a role for neuronal LRP4 ([@bib102]). Second, in the vertebrate central nervous system (CNS), agrin is not essential for synapse formation ([@bib17]) though LRP4 can regulate synaptic plasticity, development, and cognitive function ([@bib27]; [@bib70]), through functioning in astrocytes in some cases ([@bib84]). In this vein, the *Drosophila* genome contains an LRP4 homologue, but no clear agrin or MuSK homologues ([@bib1]), so any role for LRP4 there must be agrin-independent.

Here, we show in the *Drosophila* CNS that LRP4 is a presynaptic protein that regulates the number, architecture, and function of synapses. LRP4 functions largely through the conserved, presynaptic SR-protein kinase, SRPK79D. LRP4 and SRPK79D interact genetically and epistatically, as SRPK79D overexpression can suppress *lrp4*-related phenotypes. Unexpectedly, this role for LRP4 occurs preferentially in excitatory neurons, as impairing *lrp4* in inhibitory neurons has no effect. As little is known about the presynaptic determinants (save neurotransmitter-related enzymes and transporters) of excitatory versus inhibitory synapses, this may suggest a new mode for distinguishing such synapses from the presynaptic side. Thus, LRP4 may represent a conserved synaptic organizer that functions presynaptically, cell autonomously, and independently of agrin to coordinate synapse number and function.

Results {#s2}
=======

LRP4 is a synaptic protein expressed in excitatory neurons {#s2-1}
----------------------------------------------------------

We identified CG8909 as the fly LRP4 homologue ([Figure 1---figure supplements 1](#fig1s1){ref-type="fig"} and [2A](#fig1s2){ref-type="fig"}), which is predicted to be a single-pass transmembrane protein whose domain organization resembles that of mammalian LRP4 ([Figure 1A](#fig1){ref-type="fig"}). *Drosophila* LRP4 shares 38% identity with human LRP4 overall, 61% identity within the LDL-repeat containing extracellular portion, and 28% identity in the intracellular tail. Consistent with previous expression data from whole-brain microarrays ([@bib13]), we determined that LRP4 was expressed throughout the adult brain using antibodies against the endogenous protein ([Figure 1B--C](#fig1){ref-type="fig"}) or an *lrp4-GAL4* transgene that expresses GAL4 under the *lrp4* promoter and visualized with either Syt-HA ([Figure 1D](#fig1){ref-type="fig"}) or an HA epitope-tagged LRP4 ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). All methods revealed similar patterns of expression in the antennal lobes ([Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2C--E](#fig1s2){ref-type="fig"}), optic lobes, and higher olfactory centers including the mushroom body and the lateral horn ([Figure 1B,D](#fig1){ref-type="fig"}). Antibody specificity was validated by the complete loss of signal in a deletion (see below) of the *lrp4* coding region ([Figure 1C](#fig1){ref-type="fig"}). We further investigated LRP4 in the antennal lobe, the first olfactory processing center in the *Drosophila* CNS, which has emerged as a model circuit for studying sensory processing ([@bib101]) and whose synaptic organization was recently mapped at high resolution ([@bib57]).10.7554/eLife.27347.003Figure 1.LRP4 is a synaptic protein expressed in excitatory neurons.(**A**) Domain structure of *Drosophila* LRP4. Numbers indicate amino acids. EXT, extracellular side. INT, intracellular side. (**B**) Representative confocal image stack of a control *Drosophila* brain stained with antibodies against endogenous LRP4 (green) and Bruchpilot (inset, magenta) demonstrating expression throughout the brain. (**C**) Representative confocal image stack of an *lrp4^dalek^* null brain stained with antibodies against LRP4 (green) and Brp (inset, magenta) demonstrating antibody specificity. (**D**) Representative confocal image of a *Drosophila* brain expressing *UAS-Syt-HA* via *lrp4-GAL4* and stained with antibodies to HA (**D**, green) and N-Cadherin (inset, magenta). The expression pattern resembles that of endogenous LRP4, supporting the specificity of *lrp4-GAL4*. (**E**) Representative single slice within a single antennal lobe glomerulus of a brain processed for expansion microscopy (proExM) expressing LRP4-HA and Brp-Short-mStraw in all ORNs via *pebbled-GAL4* and stained with antibodies to HA (**E**, **E"**, green) and mStraw (**E'**-**E"**, magenta). LRP4 localizes to synaptic neuropil regions. (**F**) High magnification image of the region bounded by dashed lines in (**E**) and stained as above. Arrows indicate LRP4-HA localization adjacent to / not directly overlapping with Bruchpilot-Short. Arrowheads indicate overlapping LRP4-HA and Brp-Short localization. (**G--K**) Representative high magnification confocal stack images of neuronal cell bodies surrounding the antennal lobe in animals expressing *UAS-mCD8-GFP* via *lrp4-GAL4* and stained for antibodies against GFP (G-K, green) and other cell-type markers (**G'**-**K'**, magenta). Merge channels (**G''--K''**) show colocalization of *lrp4* with the neuronal marker ELAV (**G''**) but not the glial cell marker Repo (**H''**). Neurons positive for *lrp4* show colocalization with choline acetyltransferase (ChAT, **I''**), and the vesicular glutamate transporter (vGlut, **J''**), but little to no colocalization with the inhibitory neurotransmitter GABA (**K''**), suggesting that *lrp4*-positive cells are largely excitatory neurons. The percentage of GFP-positive cells that are ALSO positive for the cell-type specific marker are as follows: Elav = 99.50 ± 0.19% overlap; Repo = 0.38 ± 0.18% overlap; ChAT = 59.13 ± 2.48% overlap; vGlut = 22.38 ± 1.28% overlap; GABA = 0.25 ± 0.16% overlap. For all cases, *n* = 8 animals, ≥ 200 cells per animal. Values = mean ± s.e.m. Scale bars = 50 µm (**B--D**), 150 μm (B-D, insets), 25 μm (**E--F**), 10 μm (**G--K**).**DOI:** [http://dx.doi.org/10.7554/eLife.27347.003](10.7554/eLife.27347.003)10.7554/eLife.27347.004Figure 1---figure supplement 1.Sequence alignment of *Drosophila*, mouse, and human LRP4 homologues.Multiple sequence alignment of *Drosophila* LRP4 (CG8909; accession AAF48538.1), *Mus musculus* LRP4 (accession NP_766256.3), and Homo sapiens LRP4 (accession NP_002325.2). Red shading = identical residues. Yellow shading = similar residues. The transmembrane domains are underlined. Considerable identity is seen throughout the extracellular side of the protein, and stretches of identity and similarity are also observed in the intracellular side. Asterisks denote a putative internalization signal, NPxY ([@bib35]), which is conserved on the intracellular side of all three species.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.004](10.7554/eLife.27347.004)10.7554/eLife.27347.005Figure 1---figure supplement 2.LRP4 reagents and patterns of LRP4 expression.(**A**) Genomic region of *lrp4*. Top bar represents physical position on the X chromosome (in base pairs), and the blue arrow represents the *lrp4* genomic region flanked by other genes (yellow). Primer sets are indicated by forward and reverse arrows (see B). The exon structure is displayed with 5' and 3' UTRs shaded in gray and coding exons numbered and shaded in beige. The region deleted by the *lrp4^dalek^* mutation is indicated in pink. RNAi targets are shown below in orange. The position of the GAL4 in the *GMR90B08-GAL4* line is shown below and region of the protein against which antibodies were raised are noted below. (**B**) PCR analysis of genomic DNA from control and *lrp4^dalek^* adults. The presence of bands corresponding to Exon 2 and Exon 7--8 in control and heterozygous flies and their absence in *lrp4^dalek^* demonstrate loss of the coding region. The presence of a 315 bp band in heterozygous and homozygous *lrp4^dalek^* flies (Flank) but not in control is a result of non-homologous end joining of the 5' and 3' UTRs following deletion of the gene. (**C**) Representative confocal maximum intensity projections of the antennal lobe region of an *lrp4-GAL4* animal expressing HA-tagged LRP4 and stained with antibodies to HA (**C**, **C''**, green) and N-Cadherin (**C'**-**C''**, magenta). LRP4-HA localizes to regions of synaptic neuropil, similar to endogenous staining ([Figure 1](#fig1){ref-type="fig"}). (**D--E**) Representative confocal maximum intensity projections of antennal lobes in animals expressing *UAS-FRT-Stop-FRT-mCD8-GFP* using *lrp4-GAL4* but where FLP expression (removing the stop codon) is restricted to either ORNs using *eyFLP* (**D**) or PNs using *GH146-FLP* (**E**) and stained with antibodies to GFP (green) and N-Cadherin (magenta). Intersectional analysis reveals *lrp4* expression in both ORNs as well as PNs. Scale bars = 10 µm (**C**), 5 μm (**D--E**).**DOI:** [http://dx.doi.org/10.7554/eLife.27347.005](10.7554/eLife.27347.005)10.7554/eLife.27347.006Figure 1---figure supplement 3.Validation of expansion microscopy in *Drosophila*.(**A**) A representative *Drosophila* brain stained with antibodies against endogenous Brp (green) and processed for proExM. Organization of the fly brain is maintained as are identifiable landmarks. (inset) Unexpanded brain stained with antibodies against Brp, shown at the same scale as the expanded brain. Individual Brp puncta are resolvable in the expanded brain but not in the unexpanded brain. (**B**) A representative antennal lobe in a *Drosophila* brain expressing Brp-Short-mStraw (magenta) in all ORNs using the *pebbled-GAL4* driver and stained with antibodies against mStraw (magenta). Following proExM processing, glomerular structure and fine synaptic detail are still present. (inset) An equivalent single section from a different brain of the same genotype. In all cases, note the 4--5 fold isotropic expansion of tissue allowing for enhanced resolution while still using confocal microscopy. Scale bars as indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.006](10.7554/eLife.27347.006)

LRP4 was enriched in the synaptic neuropil of the antennal lobe ([Figure 1B](#fig1){ref-type="fig"}). As this neuropil is made up of processes from multiple classes of olfactory neurons, all of which make presynaptic connections there, we used intersectional strategies with *lrp4-GAL4* to identify which neurons expressed *lrp4*. These approaches revealed *lrp4* expression in both olfactory receptor neurons (ORNs; [Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}) and projection neurons (PNs; [Figure 1---figure supplement 2E](#fig1s2){ref-type="fig"}). Because of the observed neuropil expression of LRP4 ([Figure 1B--C](#fig1){ref-type="fig"}), we sought to examine the localization of LRP4 with regards to a known synaptic protein, the active zone scaffolding component Bruchpilot ([@bib98]). However, due to the density of CNS neuropil, colocalization analyses using light level microscopy have inherently low resolution. Therefore, we applied expansion microscopy ([@bib11]) to the *Drosophila* CNS to improve the resolution of colocalization analysis. This technique uses isotropic expansion of immunolabeled tissue ([@bib91]) while maintaining the spatial relationship between protein targets and allowing for enhanced resolution with confocal microscopy. Using protein-retention expansion microscopy (proExM), we obtained reliable, \~4 fold isotropic expansion of *Drosophila* CNS tissue ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). To specifically examine the relationship between LRP4 and active zones only in ORNs, we expressed HA-tagged LRP4 and Brp-Short-mStraw using the *pebbled-GAL4* driver ([@bib86]). LRP4-HA expressed using *lrp4-GAL4* localizes to similar regions as LRP4 antibody staining ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}), suggesting the fidelity of this transgene. Within individual expanded glomeruli of proExM-treated brains, LRP4 and Brp localized to similar regions ([Figure 1E](#fig1){ref-type="fig"}) and, when examined at high magnification, LRP4 localized either coincidentally with Brp ([Figure 1F](#fig1){ref-type="fig"}, arrowhead) or to the space adjacent to active zones ([Figure 1F](#fig1){ref-type="fig"}, arrow). This combination of active zone and periactive zone localization is similar to that of known synaptic organizers ([@bib38]; [@bib49]; [@bib56]). Thus, LRP4 is a synaptic protein that localizes to nerve terminals.

Given widespread expression throughout the brain, we sought to identify the cell types that express LRP4. To accomplish this, we used *lrp4-GAL4* driven mCD8-GFP as this approach, in addition to labeling similar neuropil regions as the antibody, also highlighted the cell bodies of *lrp4*-positive cells. We co-stained brains for various cellular and neuronal-subtype markers and quantified the overlap between cells positive for *lrp4*-expression and expression of these various labels. Nearly all *lrp4*-positive cells observed (99.5%) expressed the neuronal marker ELAV ([@bib73]) ([Figure 1G](#fig1){ref-type="fig"}), indicating that these cells were neurons. Few (0.4%) expressed the glial marker Repo ([@bib104]) ([Figure 1H](#fig1){ref-type="fig"}). The majority of *lrp4*-positive cells (59.1%) also expressed choline acetyltransferase (ChAT; [Figure 1I](#fig1){ref-type="fig"}), a marker for cholinergic excitatory neurons. We also observed partial overlap between *lrp4*-positive neurons and vGlut (22.4%; [Figure 1J](#fig1){ref-type="fig"}), the vesicular transporter for glutamate. In the fly brain, glutamatergic neurons can be either excitatory or inhibitory ([@bib51]). Interestingly, there was little overlap (0.3%) between *lrp4* and GABA, the major inhibitory neurotransmitter in *Drosophila* ([Figure 1K](#fig1){ref-type="fig"}). Thus, LRP4 is expressed at synaptic terminals of a subset of excitatory cholinergic neurons and a subset of glutamatergic neurons that may be excitatory or inhibitory, but is excluded from inhibitory GABAergic neurons.

Perturbing presynaptic LRP4 changes ORN synapse number {#s2-2}
------------------------------------------------------

As both the expression and localization of LRP4 were consistent with the protein serving a synaptic role, we sought to determine whether disrupting its function in excitatory neurons would affect synapse number. To image these connections, we expressed fluorescently tagged synaptic markers ([@bib25]; [@bib48]; [@bib57]) and used previously established methods to estimate the number of active zones and postsynaptic receptor puncta ([@bib57]) in olfactory neurons in antennal lobe glomeruli ([Figure 2A](#fig2){ref-type="fig"}). These methods show stereotyped active zone numbers and densities in ORNs and can reveal the function of synaptic proteins in mediating these aspects ([@bib57]). Further, measurements from these methods are consistent with our own electron microscopy ([@bib57]) as well as results from ultrastructural reconstructions of all synapses in individual glomeruli ([@bib92]) demonstrating their utility. To perturb LRP4 function, we created a null mutation (*lrp4^dalek^*) using the CRISPR-Cas9 system ([@bib30]) that removed the entire coding region ([Figure 1---figure supplement 2A--B](#fig1s2){ref-type="fig"}). *lrp4^dalek^* mutants were viable with a slightly reduced body size.10.7554/eLife.27347.007Figure 2.LRP4 perturbation in excitatory neurons alters synapse number.(**A**) Schematic diagram of the fly brain with major regions labeled and the olfactory regions examined in this study shaded in red (AL, antennal lobe) or yellow (LH, the lateral horn). Olfactory receptor neurons (ORNs, black), excitatory projection neurons (ePNs, red), and local interneurons (LNs, brown) are indicated. White dashed lines represent a glomerulus. Magnification: the antennal lobe region with the three glomeruli examined here highlighted: DA1 (green), VA1d (blue), and VA1v (purple). (**B--E**) Representative high magnification confocal stack images of VA1v ORN axon terminals in the VA1v glomerulus of males expressing Brp-Short-mStraw and stained with antibodies against mStraw (red) and N-Cadherin (blue). Loss of *lrp4* (*lrp4^dalek^*) and RNAi against *lrp4* expressed only in ORNs (*ORN lrp4^IR-2^*) show fewer Brp-Short-mStraw puncta while LRP4 overexpression in ORNs (*ORN LRP4 OE*) increases the number of Brp-Short-mStraw puncta. (**F--G**) Representative high magnification confocal maximum intensity projections of DA1 and VA1d PN dendrites in males expressing Dα7-EGFP, a tagged acetylcholine receptor subunit. Loss of *lrp4 (lrp4^dalek^)* also results in fewer Dα7-EGFP puncta. (**H**) Quantification of Brp-Short-mStraw puncta (red, left axis) and neurite volume (black, right axis) in VA1v ORNs. (**I**) Quantification of Dα7-EGFP puncta (green, left axis) and neurite volume (black, right axis). \*\*\*\*p\<0.0001; \*\*\*p\<0.001; ns, not significant. Statistical comparisons in 2H (one-way ANOVA with correction for multiple comparisons) are with control. Statistical comparisons between two samples are done via Student's t-test. Error bars represent mean ± s.e.m. *n* (antennal lobes) is noted at the bottom of each column. Scale bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.007](10.7554/eLife.27347.007)10.7554/eLife.27347.008Figure 2---figure supplement 1.Representative antennal lobe images for genetic *lrp4* manipulations.(**A--D**) Representative high magnification confocal maximum intensity projections of VA1v ORN axon terminals in males expressing Brp-Short-mStraw and stained with antibodies against mStraw (red) and N-Cadherin (blue). Loss of *lrp4* using independent RNAi transgenes expressed only in ORNs all result in fewer Brp-Short-mStraw puncta. (**E--K**) Representative high magnification confocal maximum intensity projections of VA1v ORN axon terminals in males expressing mCD8-GFP and stained with antibodies against GFP (green) and N-Cadherin (blue). mCD8-GFP staining (and thus, neurite volume) is unchanged by loss of *lrp4* via null mutation (F, *lrp4^dalek^*) or ORN expressed RNAi (G-J, *ORN lrp4^IR1-4^*), or LRP4 overexpression (K, *ORN LRP4 OE*). (**L--M**) Representative high magnification confocal stack images of DA1 and VA1d PN dendrites expressing membrane-tagged tdTomato (mtdT) and stained with antibodies against tdTomato (red). Loss of *lrp4* (**M**) does not affect neurite volume as measured by surface rendering of tdTomato staining. Scale bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.008](10.7554/eLife.27347.008)10.7554/eLife.27347.009Figure 2---figure supplement 2.*lrp4* perturbation in females affects synapse number.(**A--E**) Representative high magnification confocal maximum intensity projections of VA1v ORN axon terminals in females expressing Brp-Short-mStraw and stained with antibodies against mStraw (red) and N-Cadherin (blue). Loss of *lrp4* using independent RNAi transgenes expressed in ORNs (b-e, *ORN lrp4^IR-1-4^*) result in fewer Brp-Short-mStraw puncta. Note that VA1v is sexually dimorphic in size and synapse number ([@bib57]; [@bib83]) hence we examined males and females separately. (**F--J**) Representative high magnification confocal maximum intensity projections of VA1v ORN axon terminals in females expressing mCD8-GFP and stained with antibodies against GFP (green) and N-Cadherin (blue). In all cases, mCD8-GFP staining is unaffected by *lrp4* loss. (**K--L**) Representative high magnification confocal maximum intensity projection of VA1v ORNs in females expressing Brp-Short-mStraw (**K**) or mCD8-GFP (**L**) while concomitantly overexpressing LRP4 and stained with antibodies against mStraw (**K**, red) or GFP (**L**, green) and N-Cadherin (blue). LRP4 overexpression increases Brp-Short-mStraw puncta number without affecting mCD8-GFP staining. (**M**) Quantification of Brp-Short-puncta (red, left axis) and neurite volume (black, right axis) in ORNs. In both cases, *n* (antennal lobes) is noted at the bottom of each column. \*\*\*\* p\<0.0001; ns, not significant. Statistical comparisons (one-way ANOVA corrected for multiple comparisons) are with control unless noted. Error bars represent mean ± s.e.m. *n* (antennal lobes) is noted at the bottom of each column. Scale bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.009](10.7554/eLife.27347.009)10.7554/eLife.27347.010Figure 2---figure supplement 3.*lrp4* RNAi reduces synapse number in multiple glomeruli.(**A--I**) Representative high magnification confocal maximum intensity projections of ORN axon terminals in males expressing Brp-Short-mStraw (red) projecting to the DL4 and DM6 (**A--C**), VA1d (**D--F**), or DA1 glomeruli (**G--I**) and stained with antibodies to mStraw (red) and N-Cadherin (blue). RNAi-mediated knockdown of *lrp4* reduces Brp-Short puncta number in multiple glomeruli (**B--C**,**E--F**,**H--I**) demonstrating that *lrp4* generally affects synapse number in olfactory glomeruli and is not restricted to the VA1v ORNs. (**J**) Quantification of Brp-Short-mStraw puncta expressed as a percentage of control puncta for different glomeruli. For all glomeruli, a similar reduction in puncta number was observed. \*\*\*\*p\<0.0001. Statistical comparisons (one-way ANOVA with correction for multiple comparisons) are with control. Error bars represent mean ± s.e.m. *n* (antennal lobes) is noted at the bottom of each column. Scale bars = 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.010](10.7554/eLife.27347.010)10.7554/eLife.27347.011Figure 2---figure supplement 4.*lrp4* RNAi reduces Syd1 puncta in presynaptic ORN terminals.(**A--C**) Representative high magnification confocal maximum intensity projections of DA1 ORN axon terminals in males expressing DSyd1-GFP and stained with antibodies to GFP (green) and N-Cadherin (blue). Presynaptic knockdown of *lrp4* (B, *lrp4^IR-1^*; C, *lrp4^IR-2^*) reduces the number of DSyd1-GFP puncta when compared to Control (**A**). (**D**) Quantification of DSyd1-GFP puncta. \*\*\*\*p\<0.0001. Statistical comparisons (one-way ANOVA corrected for multiple comparisons) are with control unless noted. Error bars represent mean ± s.e.m. *n* (antennal lobes) is noted at the bottom of each column. Scale bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.011](10.7554/eLife.27347.011)

In ORN axon terminals projecting to the VA1v glomerulus in males ([Figure 2B](#fig2){ref-type="fig"}), *lrp4^dalek^* mutants ([Figure 2C,H](#fig2){ref-type="fig"}) showed a 31% reduction in the number of puncta for Brp-Short, an active zone marker, compared to control adults ([Figure 2B,H](#fig2){ref-type="fig"}). This phenotype was recapitulated when we expressed any of four independent transgenic RNAi constructs against *lrp4* only in ORNs ([Figure 2D,H](#fig2){ref-type="fig"}, and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), demonstrating that LRP4 functions presynaptically in regulating active zone number. These changes were independent of glomerular volume: *lrp4* loss-of-function had no effect on neurite volume ([Figure 2H](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Though the intensity of Brp-Short puncta across some genotypes trended slightly downward, it did not reach statistical significance (data not shown). We also observed that *lrp4* disruption (using *lrp4^dalek^* mutants and presynaptic RNAi expression) caused a quantitatively similar reduction of active zone numbers in VA1v ORN axon terminals in females in this sexually dimorphic glomerulus ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), and in ORN axon terminals projecting to the VA1d, DA1, DL4, and DM6 glomeruli ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). This suggests that *lrp4* phenotypes are not specific to particular glomeruli. Beyond Brp-Short, we observed similar phenotypes with an independent presynaptic marker, DSyd-1 ([@bib67]), that is also punctate at ORN terminals ([@bib57]) ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}).

We further examined the consequences of *lrp4* disruption on the number of Dα7 acetylcholine receptor puncta in PN dendrites postsynaptic to the ORN axon terminals imaged above. Loss of *lrp4* decreased Dα7-EGFP puncta numbers by 29% compared to controls ([Figure 2F--G,I](#fig2){ref-type="fig"}). This deficit was also independent of neurite volume ([Figure 2I](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), again demonstrating that *lrp4* perturbation phenotypes did not result from decreased neuronal projection size. Further, both the presynaptic active zone and postsynaptic acetylcholine receptor phenotypes were quantitatively similar. While likely that the postsynaptic AChR number decreases concomitantly with the presynaptic active zone number (which is controlled by presynaptic LRP4), we cannot exclude an additional postsynaptic role for LRP4 (see Discussion). However, it is evident that the loss of LRP4 reduces synapse number as assayed both pre- and postsynaptically.

The above experiments demonstrated the necessity of presynaptic LRP4 in ensuring the proper number of synaptic connections. However, with known presynaptic organizers like Neurexin, overexpression results in added boutons ([@bib49]) and active zones ([@bib16]). To test for LRP4 sufficiency in synapse addition, we overexpressed HA-tagged LRP4 presynaptically in otherwise wild-type ORNs. LRP4 overexpression increased the number of Brp-Short puncta by 30% ([Figure 2E,H](#fig2){ref-type="fig"}, and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}); this increase was also independent of neurite volume ([Figure 2h](#fig2){ref-type="fig"} and [Figure 2---figure supplements 2](#fig2s2){ref-type="fig"}--[3](#fig2s3){ref-type="fig"}) as the glomeruli remained the same size. Thus, there is a direct relationship between presynaptic LRP4 expression and synapse number in excitatory neurons: removing LRP4 reduces, while overexpressing LRP4 increases, synapse number.

Ultrastructural analysis reveals LRP4 regulates active zone number and structure {#s2-3}
--------------------------------------------------------------------------------

Though light level analyses accurately report fold-changes in synapse number ([@bib12]; [@bib57]), we sought to independently confirm and extend our analyses using electron microscopy. Using transmission electron microscopy (TEM) on the fly antennal lobe, we quantified synapse number in putative ORN terminals based on morphology ([@bib76]; [@bib92]) in both control ([Figure 3A](#fig3){ref-type="fig"}) and *lrp4^dalek^* ([Figure 3B](#fig3){ref-type="fig"}) adult brains. T-bar profiles were evident in both genotypes, but were reduced in number by 31% in mutant terminals ([Figure 3C](#fig3){ref-type="fig"}), which exactly matched the reduction observed by Brp-Short puncta measurements ([Figure 2H](#fig2){ref-type="fig"}). Terminal perimeter was slightly but significantly increased in *lrp4^dalek^* terminals ([Figure 3D](#fig3){ref-type="fig"}), resulting in a 36% reduction in T-bar density when compared to control ([Figure 3E](#fig3){ref-type="fig"}). These results are consistent with those observed via confocal microscopy, and demonstrate that LRP4 is necessary for the proper number of synapses in putative ORN terminals of the antennal lobe.10.7554/eLife.27347.012Figure 3.Loss of LRP4 causes defects in T-bar number and morphology.(**A--B**) Representative transmission electron micrographs of putative ORN terminal in *Control* (**A**) and *lrp4^dalek^* (**B**) adult antennal lobes. Loss of *lrp4* results in fewer observed T-bar profiles (asterisk) and a larger terminal perimeter. Scale bar = 1 µm. (**C**) Quantification of T-bar profiles per terminal in *Control* and *lrp4^dalek^* terminals. Loss of LRP4 results in a 31% reduction of T-bars. (**D**) Quantification of terminal perimeter in *Control* and *lrp4^dalek^* adults. Mutant terminals have a 13% greater perimeter than control terminals. (**E**) Quantification of the T-bar density per µm of terminal perimeter. Loss of LRP4 causes a 36% reduction in T-bar density when the increased terminal perimeter is accounted for. For (**C--E**), Control has *n* = 5 animals, 2688 terminals and *lrp4^dalek^* has *n* = 3 animals, 3123 terminals. The number of terminals measured is listed below the genotype. \*\*\*\*p\<0.0001. Statistical comparisons (two-tailed Student's t-test) are done between genotypes. Error bars represent mean ± s.e.m. (**F--H**) Representative transmission electron micrographs of individual T-bar profiles (asterisk) in *control* adults. Single (**F**), double (**G**), and triple (**H**) profiles are readily visible. (**I--Q**) Representative transmission electron micrographs of individual T-bar profiles in *lrp4^dalek^* adults. As in control flies, single (**I**), double (**J**) and triple (**K**) T-bar profiles were visible. The majority of T-bars, however, demonstrated morphology defects including those that lacked table tops (**L**), were detached from the membrane (**M--N**), were misshapen (**N--P**), and profiles containing four or more connected T-bars (**Q**). These all represent morphological defects that are not observed (or very rarely observed) in control adults. Scale bar = 200 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.012](10.7554/eLife.27347.012)

Brp-Short assays alone cannot distinguish between normal and impaired active zones. We therefore examined the ultrastructural morphology of individual active zones to determine if LRP4 had an additional role in the biogenesis of the T-bar itself. In both control ([Figure 3F--H](#fig3){ref-type="fig"}) and *lrp4* ([Figure 3I--K](#fig3){ref-type="fig"}) terminals, we observed single ([Figure 3F--I](#fig3){ref-type="fig"}), double ([Figure 3G,J](#fig3){ref-type="fig"}), and triple T-bars ([Figure 3H,K](#fig3){ref-type="fig"}) suggesting that LRP4 is not absolutely required for T-bar formation and some elements of organization. However, whereas irregular T-bars in control animals were rare (\<5% of total T-bars), the majority of T-bars in *lrp4* mutants displayed one or more defects ([Figure 3L--Q](#fig3){ref-type="fig"}), including immature T-bars that lacked tops ([Figure 3L](#fig3){ref-type="fig"}), detached T-bars ([Figure 3M](#fig3){ref-type="fig"}), misshapen T-bars of varying configurations and aggregations ([Figure 3N--P](#fig3){ref-type="fig"}), and multiple T-bars beyond those observed in control animals ([Figure 3Q](#fig3){ref-type="fig"}). Thus, in addition to controlling the number of synapses, LRP4 is also required for individual active zones to assume normal morphology, attach to the membrane, and have proper spacing. Thus, LRP4 has multiple, critical roles in central synapse formation.

LRP4 is not required for inhibitory neuron synapse number {#s2-4}
---------------------------------------------------------

The preferential expression of *lrp4* in excitatory but not inhibitory neurons ([Figure 1](#fig1){ref-type="fig"}) suggests that it promotes synapse addition specifically in excitatory neurons. To test this, we used Brp-Short to examine synapse number in GABAergic inhibitory neurons projecting to the antennal lobe using the *GAD1-GAL4* driver ([@bib62]). Though GAD1-positive neurons project throughout the antennal lobe ([@bib54]), we restricted our analyses to the DA1 glomerulus, where we observed reductions in excitatory synapses ([Figure 2---figure supplements 3](#fig2s3){ref-type="fig"}--[4](#fig2s4){ref-type="fig"}) following LRP4 disruption. When LRP4 function was impaired using the *lrp4^dalek^* mutant or RNAi in these neurons, synapse number was unaffected ([Figure 4A--B,D](#fig4){ref-type="fig"}). Thus, the reduction of synapse number under LRP4 loss-of-function conditions appeared specific for excitatory neurons.10.7554/eLife.27347.013Figure 4.Effects of LRP4 perturbation on inhibitory neuron synapse formation.(**A--C**) Representative high magnification confocal maximum intensity projections of GAD1-positive inhibitory neurons, which project to the DA1 glomerulus (dashed line), in males expressing Brp-Short-mStraw and stained with antibodies against mStraw (red) and N-Cadherin (blue). Due to the proximity of inhibitory neuron cell bodies to the antennal lobe, saturated somatic signal is observed. Loss of *lrp4* (*lrp4^dalek^*) does not affect puncta number but overexpression of LRP4 (*GAD1 LRP4 OE*) increases Brp-Short puncta. (**D**) Quantification of Brp-Short-mStraw puncta (red, left axis) and neurite volume (black, right axis) in GAD1 neurons. Neither loss of *lrp4* nor RNAi against *lrp4* expressed in inhibitory neurons affects puncta number or neurite volume. \*\*\*\*p\<0.0001; \*\*\*p\<0.001; ns, not significant. Statistical comparisons (one-way ANOVA with correction for multiple comparisons) are with control. Error bars represent mean ± s.e.m. *n* (antennal lobes) is noted at the bottom of each column. Scale bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.013](10.7554/eLife.27347.013)

Interestingly, when LRP4 was overexpressed in inhibitory neurons, we observed a 35% increase in synapse number without an accompanying change in neurite volume, similar to what we observed for excitatory neurons ([Figure 4C--D](#fig4){ref-type="fig"}). This suggests that, while inhibitory GABAergic neurons do not normally utilize LRP4 to regulate synapse number, they possess the downstream machinery necessary for LRP4 to function in adding synapses. Thus, when LRP4 is exogenously expressed in these cells, it can co-opt this machinery for synapse addition. As such, excitatory and inhibitory neurons likely use distinct cell surface synaptic organizers (LRP4 for excitatory neurons) that converge on common mechanisms for synapse addition.

Excitatory, but not inhibitory, olfactory projection neurons also require LRP4 to ensure proper synapse number {#s2-5}
--------------------------------------------------------------------------------------------------------------

Though we initially restricted our analyses to the antennal lobe, we also observed *lrp4* expression throughout the brain, including two higher order olfactory neuropil: the mushroom body and the lateral horn ([Figure 1B--D](#fig1){ref-type="fig"}). To determine whether LRP4 could also serve as a synaptic organizer in these brain regions, we examined the effects of *lrp4* perturbation on both excitatory and inhibitory synapses in the lateral horn (LH, [Figure 5A](#fig5){ref-type="fig"}), a higher order olfactory center involved in innate olfactory behavior ([@bib32]). We used *Mz19-GAL4* to label projection neurons whose dendrites and cell bodies are restricted to the antennal lobe region, but whose axon terminals make excitatory synapses in the lateral horn ([@bib7]). To label inhibitory synapses, we used the *Mz699-GAL4* driver, which is expressed in inhibitory projection neurons (iPNs) whose dendrites project to the antennal lobe and whose axons project to the lateral horn ([@bib43]; [@bib50]). *Mz699-GAL4* also labels a small subset of third-order neurons that project dendrites largely void of presynaptic terminals to the ventral lateral horn ([@bib50]). Thus, we consider synaptic signal labeled by *Mz699-GAL4* as being contributed mostly by iPNs.10.7554/eLife.27347.014Figure 5.LRP4 perturbations similarly affect higher order olfactory centers.(**A**) Schematic diagram of the fly brain with major regions labeled and the olfactory regions examined in this study shaded in red (AL, antennal lobe) or yellow (LH, the lateral horn). Excitatory projection neuron (ePN, dark red) and inhibitory projection neuron (iPN, teal) axons are indicated. Magnification: the lateral horn region with the regions innervated by excitatory Mz19-positive projection neuron axons (ePNs, dark red) and inhibitory Mz699-positive projection neuron axons (iPNs, teal) examined here highlighted. (**B--C**) Representative high magnification confocal maximum intensity projections of *Mz19-GAL4* positive PN axon terminals in the lateral horn in males expressing Brp-Short-mStraw and mCD8-GFP and stained for antibodies against mStraw (red), GFP (green), and N-Cadherin (blue). Loss of *lrp4* (**B**, *lrp4^dalek^*) reduces synapse number compared to control (**A**). (**D--E**) Representative high magnification confocal maximum intensity projections of *Mz699-GAL4* positive inhibitory projection neuron (iPN) axon terminals in the lateral horn in males expressing Brp-Short-mStraw and mCD8-GFP and stained for antibodies against mStraw (red), GFP (green), and N-Cadherin (blue). Loss of *lrp4* (E, *lrp4^dalek^*) does not affect synapse number compared to control (**D**). (**F**) Quantification of Brp-Short-mStraw puncta (red, left axis) and neurite volume (black, right axis) in Mz19-positive excitatory projection neurons. Loss of *lrp4* and RNAi against *lrp4* expressed in those neurons reduces puncta number but leaves neurite volume unaffected. The similar reduction in puncta number between mutants and PN-specific RNAi reveals the cell autonomous nature of the *lrp4* phenotype. (**G**) Quantification of Brp-Short-mStraw puncta (red, left axis) and neurite volume (black, right axis) in Mz699-positive inhibitory projection neurons. Neither loss of *lrp4* nor *lrp4* RNAi expressed in those neurons affects puncta number, similar to inhibitory neurons in the antennal lobe. Loss of *lrp4* reduces neurite volume by 11% but RNAi does not. Overexpression of LRP4 in these neurons (*LRP4 OE*) results in a 28% increase in the number of Brp-Short puncta. \*\*\*\*p\<0.0001; \*\*p\<0.01; ns, not significant. Statistical comparisons (one way ANOVA with correction for multiple comparisons) are with control. Error bars represent mean ± s.e.m. *n* (lateral horns) is noted at the bottom of each column. Scale bars = 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.014](10.7554/eLife.27347.014)10.7554/eLife.27347.015Figure 5---figure supplement 1.Representative lateral horn images for LRP4 genetic manipulations.(**A--C**) Representative high magnification confocal maximum intensity projections of *Mz19-GAL4* positive PN axon terminals in the lateral horn in males expressing Brp-Short-mStraw and mCD8-GFP and stained for antibodies against mStraw (red), GFP (green), and N-Cadherin (blue). Presynaptic knockdown of *lrp4* (**B**, *lrp4^IR-1^*; C, *lrp4^IR-2^*) results in fewer Brp-Short puncta compared to *Control* (**A**) but does not affect mCD8-GFP staining. (**D--G**) Representative high magnification confocal stack images of *Mz699-GAL4* positive inhibitory projection neuron (iPN) axon terminals in the lateral horn in males expressing Brp-Short-mStraw and mCD8-GFP and stained for antibodies against mStraw (red), GFP (green), and N-Cadherin (blue). Presynaptic RNAi against *lrp4* (E, *lrp4^IR-1^*; F, *lrp4^IR-2^*) has no effect on Brp-Short puncta or neurite volume. Overexpression of LRP4 in these neurons (G, LRP4 OE), however, increases synaptic puncta without changing neurite volume. Scale bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.015](10.7554/eLife.27347.015)

In *lrp4* mutants, the number of excitatory lateral horn synapses was reduced by 40%, consistent with a role for LRP4 in synapse formation ([Figure 5B--C,F](#fig5){ref-type="fig"}). PN perturbation of *lrp4* using RNAi reduced synapse number similarly to the loss-of-function allele, demonstrating a presynaptic role for *lrp4* in these neurons ([Figure 5F](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). These changes were independent of neurite volume, which remained unaffected ([Figure 5F](#fig5){ref-type="fig"}). Perturbation of *lrp4* in *Mz699*-positive iPNs, however, had no effect on the number of synapses ([Figure 5D--E,G](#fig5){ref-type="fig"}, and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) despite a slight reduction in neurite volume in *lrp4^dalek^* mutants ([Figure 5G](#fig5){ref-type="fig"}). Despite a lack of a loss-of-function phenotype, we observed an increase in synapse number when we overexpressed LRP4-HA in *Mz699*-positive neurons ([Figure 5G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Thus, the results of *lrp4* perturbation on excitatory and inhibitory synapses in the lateral horn resembled those of the antennal lobe, suggesting a general role for LRP4 in promoting excitatory synapse number.

LRP4 is required for normal olfactory attraction behavior {#s2-6}
---------------------------------------------------------

Given the role for LRP4 in the specific regulation of excitatory synapse number, we sought to determine whether the consequences of LRP4 disruption were accompanied by functional changes in behavior. We examined fly attraction to the odorant in apple cider vinegar using a modified olfactory trap assay ([@bib45]; [@bib71]) ([Figure 6A](#fig6){ref-type="fig"}), an ethologically relevant assay that requires flight and/or climbing to follow odorant information within a larger arena ([@bib55]). As presynaptic LRP4 regulates ORN synapse number, we used RNAi against *lrp4* expressed selectively in all ORNs using *pebbled-GAL4* to assess olfactory attraction. Control flies bearing a single copy of *pebbled-GAL4* or one of four different *lrp4* RNAi transgenes alone exhibited a strong preference for apple cider vinegar ([Figure 6B](#fig6){ref-type="fig"}). Flies bearing both transgenes (and thus, reduced *lrp4* expression) exhibited a near complete abrogation of attractive behavior and were no longer able to distinguish the attractive apple cider vinegar from a water control ([Figure 6B](#fig6){ref-type="fig"}). Movement, wall climbing, and flight were still observed in these flies (data not shown), suggesting that this was not due to widespread defects in motion, consistent with our selective perturbation of LRP4 function in ORNs. Thus, presynaptic LRP4 in ORNs is necessary for normal olfactory attraction behavior.10.7554/eLife.27347.016Figure 6.Loss of presynaptic LRP4 abolishes olfactory attraction behavior.(**A**) Cartoon of the olfactory trap. (**B**) Quantification of preference index \[(\# of flies in odor vial -- \# of flies in control vial) / total \# of flies\] between apple cider vinegar (odor) and water (ctrl). Genotypes are indicated below. Control flies with only a *GAL4* or *UAS-RNAi* transgene demonstrate high preference for the attractive odorant in apple cider vinegar. Flies expressing *lrp4* RNAi in ORNs have this attraction abrogated. Flies expressing RNAi against GABA~B~R2 in ORNs still display robust attractive behavior while concurrent expression with *lrp4* knockdown largely suppresses the loss of attractive behavior. To ensure an equivalent number of transgenes in each genotype, *UAS-mCD8-GFP* was included (not listed) to control for potential transgenic dilution. \*\*\*\*p\<0.0001; \*\*p\<0.01; \*p\<0.05; ns, not significant. Statistical comparisons (one-way ANOVA with correction for multiple comparisons) are with control unless otherwise noted. Error bars represent mean ± s.e.m. *n* (cohorts of 25 flies tested) is noted at the bottom of each column.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.016](10.7554/eLife.27347.016)

A complete loss of olfactory attraction was unexpected for a manipulation that reduced synapse number by \~30%. One potential explanation is that, while the remaining 70% of synapses were detected by the Brp-Short assay, they were functionally impaired. This would be consistent with the myriad of morphology defects observed in *lrp4* mutant T-bars via TEM ([Figure 3I--Q](#fig3){ref-type="fig"}). In *Drosophila*, olfactory information flow is regulated by presynaptic inhibition by local GABAergic interneurons onto excitatory ORNs via the GABA~A~ and GABA~B~R2 receptors ([@bib65]; [@bib75]). If the remaining synapses were indeed weakened by the loss of LRP4, reducing inhibition onto those ORNs might suppress the behavioral phenotype. To test this hypothesis, we inhibited the GABA~B~R2 receptor in ORNs using RNAi, which by itself did not affect the olfactory attraction behavior ([Figure 6B](#fig6){ref-type="fig"}). Simultaneous knockdown of *GABA~B~R2* and *lrp4*, however, markedly suppressed the behavioral phenotype associated with *lrp4* knockdown alone ([Figure 6B](#fig6){ref-type="fig"}). This manipulation did not suppress the morphological phenotype, however, as the reduction in Brp-Short puncta was still apparent (1297 ± 25.62 puncta, *n* = 39 antennal lobes for *Or47b-GAL4 \> UAS-lrp4^IR2^* + *UAS-mCD8-GFP* vs. 1191 ± 48.91 puncta, *n* = 12 antennal lobes for *Or47b-GAL4 \> UAS-lrp4^IR2^ + UAS-GABABR2^IR^*, p\>0.2). These results suggest that olfactory attraction behavior requires a proper level of net excitatory drive in the antennal lobe circuit and that defects caused by weakened excitatory synapses can be compensated for by reducing inhibition.

SRPK79D interacts with, and requires, LRP4 for ORN terminal localization {#s2-7}
------------------------------------------------------------------------

To understand how LRP4 could regulate excitatory synapse number and olfactory behavior, we investigated the mechanism by which it functions. In examining *lrp4^dalek^* mutant larvae and larvae where *lrp4* was specifically knocked down in all neurons using RNAi, we observed impaired localization of active zone material ([Figure 7A--C](#fig7){ref-type="fig"}). Under normal circumstances, the active zone marker Bruchpilot ([@bib98]) and the synaptic vesicle marker Synaptotagmin I ([@bib22]) were barely detectable in larval transverse nerves ([Figure 7A](#fig7){ref-type="fig"}), due to their proper trafficking to or maintenance at synaptic sites. However, in *lrp4^dalek^* mutants, Bruchpilot improperly accumulated in the transverse nerves ([Figure 7B](#fig7){ref-type="fig"}). This kind of accumulation is rarely observed in wild type, but is also most notably associated with loss of SRPK79D ([Figure 7C](#fig7){ref-type="fig"}), a conserved serine-arginine protein kinase that localizes to NMJ terminals and negatively regulates premature active zone assembly before Bruchpilot reaches the fly NMJ ([@bib39]; [@bib63]). In both *lrp4* and *srpk79D* mutants, Brp accumulation was not accompanied by focal accumulations of Synaptotagmin I, indicating that axonal trafficking is not generally impaired ([Figure 7A--C](#fig7){ref-type="fig"}) ([@bib26]; [@bib39]; [@bib63]). Because of the similarity in the transverse nerve phenotypes and the role of SRPK79D at peripheral synapses, we hypothesized that LRP4 and SRPK79D could operate together in the CNS to regulate synapse number.10.7554/eLife.27347.017Figure 7.LRP4 is required for normal synaptic SRPK79D localization in the CNS.(**A--C**) Representative images of larval transverse nerves stained with antibodies to Bruchpilot (Brp, green), Synaptotagmin I (Syt I, red), and HRP (blue). Loss of *lrp4* (B, *lrp4^dalek^*) and *srpk79d* (C, *srpk^atc^*) result in improper axonal accumulations of Brp. This is not a general trafficking defect, as Syt I is absent from focal accumulations. (**D**) Representative high magnification confocal slice of VA1v ORNs expressing Brp-Short-mStraw and venus-SRPK79D and stained with antibodies to mStraw (red), GFP (green), and N-Cadherin (blue). SRPK79D largely colocalized with Brp-Short-mStraw but Brp-Short-positive / SRPK79D-negative and Brp-Short-negative / SRPK79D-positive puncta were also observed (**D''**). (**E**) Representative confocal slice within a single antennal lobe glomerulus of a brain expressing venus-SRPK79D and LRP4-HA in all ORNs, processed for proExM, and stained with antibodies to venus (green), HA (red), and N-Cadherin (blue). Distinct regions of overlap between venus-SRPK79D and LRP4-HA (**E"**) are observed, though this represents a subset of venus-SRPK79D localization. (**F--G**) Representative high magnification confocal maximum intensity projections of VA1v ORN axon terminals expressing venus-SRPK79D in control (**F**) and *lrp4^dalek^* (**G**) backgrounds and stained with antibodies to GFP (green) and N-Cadherin (blue, inset). Loss of *lrp4* results in reduced synaptic SRPK79D. (**H**) Quantification of venus-SRPK79D (green, left axis) and N-Cadherin fluorescence (blue, right axis). SRPK79D fluorescence is markedly reduced in *lrp4^dalek^* animals, but N-Cadherin staining is unaffected, demonstrating specificity. (**I**--**J**) Representative high magnification single confocal slices of the antennal lobe where all ORNs are expressing venus-SRPK79D and LRP4-HA via the *pebbled-GAL4* driver and the brains subsequently processed using proximity ligation assays to determine whether the two proteins were close enough to interact. The brains were stained with antibodies to venus (green) and HA (blue) and PLA-specific probes (red) to detect proximity ligation events. When PLA-specific probes are not added, no signal is observed (**I"**) but when present, positive PLA signal (**J"**) indicates close physical proximity between LRP4-HA and venus-SRPK79D. Positive PLA signal represents a subset of SRPK79D or LRP4 expression, as in (**E**). \*\*p\<0.01; ns, not significant. Statistical comparisons (one-way ANOVA with correction for multiple comparisons) are with control unless otherwise noted. Error bars represent mean ± s.e.m. *n* (antennal lobes) is noted at the bottom of each column. Scale bars = 10 µm (**A--D**,**I--J**), 25 µm (**E**), 20 µm (**F--G**), 33 µm (F-G insets).**DOI:** [http://dx.doi.org/10.7554/eLife.27347.017](10.7554/eLife.27347.017)10.7554/eLife.27347.018Figure 7---figure supplement 1.Proximity ligation assays reveal LRP4 and SRPK79D interactions.(**A--D**) Representative single confocal slices of antennal lobes expressing venus-SRPK79D alone (**A**), LRP4-HA alone (**B**) or venus-SRPK79D and LRP4-HA (**C--D**) in all ORNs using the *pebbled-GAL4* driver and stained with antibodies against venus (green), HA (blue), and processed using proximity ligation assays (red). When either protein is expressed alone (a--b), no PLA signal is observed (**A"**,**B"**). When both are present, however, PLA signal can be observed (**C"**,**D"**) suggesting that the two are close enough physically to interact. High magnification of a single glomerulus (**D"**, the dashed boundary in **C**) indicates that the PLA-positive signal represents a subset of LRP4 or SRPK79D localization. Scale bars = 20 µm (**A--B**), 10 µm (**C**), 5 µm (**D**).**DOI:** [http://dx.doi.org/10.7554/eLife.27347.018](10.7554/eLife.27347.018)

As SRPK79D antibodies are not available, we utilized Venus-tagged SRPK79D transgenes to examine CNS localization. When expressed only in VA1v ORNs, venus-SRPK79D localized to axon terminals and overlapped with Brp-Short, demonstrating localization with and adjacent to CNS active zones ([Figure 7D](#fig7){ref-type="fig"}). This was reminiscent of LRP4-HA localization in ORNs ([Figure 1F](#fig1){ref-type="fig"}) so we turned to proExM to more precisely assess the spatial relationship between SRPK79D and LRP4. In the ORNs of expanded individual glomeruli, LRP4-HA and venus-SRPK79D exhibited coincident and adjacent localization ([Figure 7E](#fig7){ref-type="fig"}). However, SRPK79D was expressed more broadly throughout ORNs, suggesting that only a subset of SRPK79D colocalizes with LRP4. This may indicate both LRP4-dependent and -independent roles for SRPK79D. We also examined this synaptic localization in *lrp4^dalek^* mutants: loss of *lrp4* reduced synaptic SRPK79D levels by \~50% ([Figure 7F--H](#fig7){ref-type="fig"}). This reduction was specific for SRPK79D, as the staining for other markers, like the general neuropil label N-Cadherin, was unaffected ([Figure 7F--H](#fig7){ref-type="fig"}). These results demonstrate that LRP4 is necessary for the proper localization and / or expression of SRPK79D and suggest that SRPK79D might act downstream of LRP4 to regulate synapse number.

Due to their spatial proximity, we next employed proximity ligation assays (PLA) to determine whether LRP4 and SRPK79D are spatially close enough to interact. PLA uses oligonucleotides conjugated to secondary antibodies ([@bib31]; [@bib82]): if the epitopes are sufficiently close (30--40 nm), the oligonucleotides can be ligated together and detected using a fluorescent probe. The result can be observed using confocal microscopy and preserve, to a high degree, the spatial localization of the proteins involved. PLA has been used to examine protein-protein interactions at the NMJ ([@bib99]) but not, to our knowledge, in the CNS. To examine this, we co-expressed venus-SRPK79D and LRP4-HA in all ORNs using *pebbled-GAL4* ([@bib86]), stained both targets with oligonucleotide-conjugated secondary antibodies and performed PLA assays ([Figure 7I--J](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). As expected, both proteins localize to the axon terminals of ORNs. When either is expressed singularly ([Figure 7---figure supplement 1A--B](#fig7s1){ref-type="fig"}) or the probes are not added ([Figure 7I](#fig7){ref-type="fig"}), no PLA signal is observed. However, in the presence of both transgenes and the appropriate probes ([Figure 7J](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1C--D](#fig7s1){ref-type="fig"}), we detected positive signal indicating that the proteins were close enough to interact. The PLA signal represented a subset of LRP4 or SRPK79D staining patterns, suggesting that there are roles independent of the other for each protein. Taken together, this data suggests that LRP4 interacts with SRPK79D to maintain SRPK79D localization at the synapse.

SRPK79D overexpression suppresses LRP4 phenotypes {#s2-8}
-------------------------------------------------

The interaction with, and reliance on LRP4 for synaptic SRPK79D localization suggested that the two function together. If so, we would expect that the two would display phenotypic similarity and interact in the same genetic pathway. We observed phenotypic similarity in larval nerves ([Figure 7A--C](#fig7){ref-type="fig"}), but we further sought to study this at CNS synapses. To test the interactions between LRP4 and SRPK79D with respect to effects of synapse number, we conducted loss-of-function, genetic interaction, and genetic epistasis experiments between genetic perturbations of both. First, reducing *srpk79D* function presynaptically using an established RNAi ([@bib39]) expressed in VA1v ORNs resulted in a 15% reduction in the number of Brp-Short puncta compared to control ([Figure 8A--B,E](#fig8){ref-type="fig"}). Thus, SRPK79D is required for normal CNS synapse number. We further sought to understand if LRP4 and SRPK79D interacted genetically. To examine this, we performed a transheterozygote genetic interaction assay. When single copies of either *lrp4* or *srpk79D* were removed, there was no evident phenotype ([Figure 8---figure supplement 1B--C,E](#fig8s1){ref-type="fig"}). However, when one copy of each was concurrently removed, we observed a significant reduction in Brp-Short puncta ([Figure 8---figure supplement 1D--E](#fig8s1){ref-type="fig"}). This suggests that the two function in the same genetic pathway and may work together to ensure proper synapse number. Given the reduction in synaptic SRPK79D present in *lrp4* mutants, we examined whether these reduced SRPK79D levels are the root cause of its synapse reduction. We overexpressed SRPK79D in presynaptic ORNs either in control or *lrp4^dalek^* mutant backgrounds. Presynaptic overexpression of SRPK79D in VA1v ORNs partially suppressed the synaptic phenotype associated with the *lrp4^dalek^* mutation, resulting in 92% of the normal number of synapses ([Figure 8A,C--E](#fig8){ref-type="fig"}), whereas overexpression of SRPK79D in a wild-type background had no effect ([Figure 8E](#fig8){ref-type="fig"}). Finally, we sought to determine whether *srpk79D* was required for the increase in Brp-Short puncta associated with LRP4 overexpression ([Figure 2H](#fig2){ref-type="fig"}). When LRP4 was overexpressed concurrently with *srpk79D* RNAi, the phenotype resembled that of *srpk79D* RNAi alone ([Figure 8E](#fig8){ref-type="fig"}). This suggests that LRP4 requires SRPK79D to mediate its overexpression phenotype, likely by functioning through SRPK79D to increase the number of synapses. Combined, these indicate that LRP4 and SRPK79D closely interact presynaptically in the same genetic pathway to ensure the proper number of excitatory synapses.10.7554/eLife.27347.019Figure 8.SRPK79D and LRP4 genetically interact to control synapse morphology and function.(**A--D**) Representative high magnification confocal maximum intensity projections of VA1v ORN axon terminals in males expressing Brp-Short-mStraw and stained with antibodies to mStraw (red) and N-Cadherin (blue). Presynaptic RNAi against *srpk79D* (*srpk RNAi*) reduces the number of puncta, but less so than loss of *lrp4* (*lrp4^dalek^*). Presynaptic overexpression of SRPK79D in an *lrp4^dalek^* background (*lrp4^dalek^ + SRPK*) restores puncta number to control levels. (**E**) Quantification of Brp-Short-mStraw puncta. Note that overexpression of SRPK79D in an otherwise wild-type background has no gain-of-function effects on puncta number. Further *srpk79D* function is needed to enable the LRP4 overexpression-induced increase in synaptic puncta number. *n* (antennal lobes) is noted at the bottom of each column. (**F**) Quantification of preference index in the olfactory trap assay. Flies overexpressing SRPK79D in ORNs show strong attractive behavior, while ORNs expressing RNAi against *lrp4* or *srpk79D* abrogate attraction to apple cider vinegar. This phenotype can be suppressed by concurrent overexpression of SRPK79D. *UAS-mCD8-GFP* (not listed) was used to ensure equivalent numbers of transgenes in each genotype. *n* (cohorts of 25 flies tested) is noted at the bottom of each column. (**G**) A model for LRP4 function at olfactory synapses. At wild-type axon terminals, LRP4 in presynaptic ORNs (orange) interacts with a putative postsynaptic partner (blue), resulting in SRPK79D (beige) retention at the terminal and a full complement of active zones (black T). Here, the putative ligand is depicted as having a postsynaptic PN source, but alternate sources (such as glia or local interneurons) are also possible. In the absence of LRP4, less synaptic SRPK79D is present and active zone number is reduced. The size of the terminal itself does not change but the synapse number (i.e., number of active zones) within that terminal space is reduced. Further, T-bar defects like a floating T-bar can also be seen. SRPK79D overexpression in an *lrp4* mutant restores synaptic SRPK79D and active zone number, despite the absence of LRP4. Thus, the LRP4 largely functions in synaptic organization through downstream SRPK79D. \*\*\*\*p\<0.0001; \*\*\*p\<0.001; ns, not significant. Statistical comparisons (one-way ANOVA with correction for multiple comparisons) are with control unless otherwise noted. Error bars represent mean ± s.e.m. *n* (antennal lobes for **E**, cohorts of 25 flies tested for **F**) is noted at the bottom of each column. Scale bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.019](10.7554/eLife.27347.019)10.7554/eLife.27347.020Figure 8---figure supplement 1.*lrp4* and *srpk79D* interact genetically to control Brp-Short puncta number.(**A--D**) Representative high magnification confocal maximum intensity projections of VA1v ORN axon terminals in the VA1v glomerulus of males expressing Brp-Short-mStraw and stained with antibodies against mStraw (red) and N-Cadherin (blue). (**E**) Quantification of Brp-Short-mStraw puncta. Loss of one copy of either *lrp4* (**B**) or *srpk79D* (**C**) does not affect puncta number, but concurrent loss of one copy of each gene (**D**) results in fewer puncta. \*p\<0.05. Statistical comparisons (one-way ANOVA corrected for multiple comparisons) are with control unless noted. Error bars represent mean ± s.e.m. *n* (antennal lobes) is noted at the bottom of each column. Scale bar = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.27347.020](10.7554/eLife.27347.020)

In light of the synapse number defects, we also examined the functional consequences of *srpk79D* perturbation on olfactory behavior. Flies expressing *srpk79D* RNAi in all ORNs demonstrated a nearly complete abrogation of attraction behavior ([Figure 8F](#fig8){ref-type="fig"}) that was indistinguishable from the *lrp4* RNAi phenotype. In light of the suppression of the synapse number phenotype, we also examined whether SRPK79D overexpression could suppress the *lrp4* loss-of-function behavioral phenotype. Control flies bearing the pan-ORN *pebbled-GAL4* or the SRPK79D overexpression transgene alone exhibited strong attraction towards apple cider vinegar ([Figure 8F](#fig8){ref-type="fig"}). Further, SRPK79D overexpression in all ORNs did not affect this robust attraction. Driving both SRPK79D overexpression and *lrp4* RNAi in all ORNs, however, resulted in a partial suppression of the behavioral phenotype associated with *lrp4* RNAi ([Figure 8F](#fig8){ref-type="fig"}). As the synaptic level of SRPK79D is positively regulated by LRP4 and SRPK79D overexpression suppresses the morphological and functional phenotypes associated with *lrp4* loss-of-function, SRPK79D is likely a key downstream effector of LRP4 in regulating synapse number and thus, normal olfactory attraction behavior.

Discussion {#s3}
==========

Understanding how synaptic organizers regulate the number and function of synapses in the CNS is a central goal of molecular neurobiology. This study identifies LRP4 as a synaptic protein whose expression may be preferential for excitatory neurons in the *Drosophila* CNS ([Figure 1](#fig1){ref-type="fig"}). Though well-known as the postsynaptic agrin receptor at the mouse NMJ ([@bib41]; [@bib107]), here we describe an agrin-independent, presynaptic role for LRP4. In the *Drosophila* CNS, LRP4 functions presynaptically to regulate the number of active zones in presynaptic ORNs ([Figures 2](#fig2){ref-type="fig"}--[3](#fig3){ref-type="fig"}) and acetylcholine receptor clusters in the PNs postsynaptic to those ORNs ([Figure 2](#fig2){ref-type="fig"}). Moreover, LRP4 also controls the morphology of individual active zones: *lrp4* mutant T-bars exhibit striking defects in patterning and biogenesis ([Figure 3](#fig3){ref-type="fig"}). These defects are specific for excitatory neurons, as inhibitory neuron synapses in the antennal lobe remain unaffected ([Figure 4](#fig4){ref-type="fig"}). Overexpression of LRP4, however, can increase synapse number cell autonomously in both excitatory and inhibitory neurons ([Figures 2](#fig2){ref-type="fig"}--[4](#fig4){ref-type="fig"}), suggesting that both share common mechanisms for synapse addition. The role for LRP4 further extends to higher order olfactory neuropil in the lateral horn ([Figure 5](#fig5){ref-type="fig"}), suggesting that it may serve a general role in synaptic organization. Underscoring the functional importance of LRP4, its perturbation in excitatory ORNs abrogated olfactory attraction behavior ([Figure 6](#fig6){ref-type="fig"}). The suppression of the behavioral phenotype by reducing presynaptic inhibition onto ORNs further suggests that a proper level of excitatory drive is important for functional circuit output. To mediate both morphological and behavioral effects, LRP4 likely functions through SRPK79D, a conserved SR-protein kinase whose loss-of-function phenotypes resemble those of *lrp4* ([Figures 7](#fig7){ref-type="fig"}--[8](#fig8){ref-type="fig"}), whose synaptic localization depends on LRP4 ([Figure 7](#fig7){ref-type="fig"}), who interacts genetically with and is physically in proximity to LRP4 ([Figures 7](#fig7){ref-type="fig"}--[8](#fig8){ref-type="fig"}), and whose overexpression suppresses the phenotypes associated with loss of *lrp4* ([Figure 8](#fig8){ref-type="fig"}).

LRP4 as a synaptic regulator that distinguishes excitatory from inhibitory presynaptic terminals {#s3-1}
------------------------------------------------------------------------------------------------

Coordination of excitation and inhibition is critical to proper circuit function. Imbalances in excitation and inhibition lead to epileptic states ([@bib4]) and social dysfunction ([@bib105]), and may also underlie many autism spectrum disorders ([@bib60]; [@bib61]). The mechanisms that maintain this balance are incompletely understood, though likely involve multiple aspects including the number of each type of neuron, their firing rates, release probabilities, synaptic strength, and neurotransmitter receptor sensitivities. Such regulation likely requires distinguishing excitatory from inhibitory neurons at both pre- and postsynaptic levels. Excitatory and inhibitory synapses are identified postsynaptically by distinct neurotransmitter receptor, scaffolding protein, and adhesion molecule repertoires ([@bib16]; [@bib78]; [@bib110]). Postsynaptic factors like Neuroligin 2 ([@bib28]), Gephyrin ([@bib14]), and Slitrk3 ([@bib89]) organize inhibitory GABAergic synapses while LRRTMs organize excitatory synapses ([@bib81]; [@bib21], [@bib20]). Thus, postsynaptic regulation can occur by differential modulation of these factors. Little is known, however, about the presynaptic identifiers of excitatory versus inhibitory neurons. Recent work identified Punctin / MADD-4 as a determinant of excitatory versus inhibitory neuromuscular synapses in *C. elegans*, though as a secreted factor that functions via postsynaptic interaction ([@bib53]; [@bib69]; [@bib94]). Further, Glypican4 can localize to excitatory presynaptic terminals and interact with LRRTM4 ([@bib20]) but its synaptogenic activity is also provided by astrocytes ([@bib3]) and thus is not neuronal specific. Proteomic comparisons ([@bib8]; [@bib10]) suggest few differences beyond those pertaining to neurotransmitter synthesis enzymes and transporters. But these components may not be sufficient to distinguish presynaptic excitatory from inhibitory neurons. In the *Drosophila* olfactory system, for example, glutamate can be inhibitory when its postsynaptic partners express glutamate-gated chloride channels ([@bib51]). This suggests that pre- and postsynaptic regulators may exist to distinguish excitatory and inhibitory synapses, though it is unclear what those presynaptic regulators might be.

Our data suggests that LRP4 may be a candidate presynaptic organizer specific for excitatory connections. LRP4 is expressed in a subset of excitatory cholinergic neurons, excluded from inhibitory GABAergic neurons, and expressed in a subset of glutamatergic neurons that may be excitatory or inhibitory ([Figure 1](#fig1){ref-type="fig"}). Though we cannot rule out inhibitory neuron expression in the case of the glutamatergic subset, the phenotypes associated with LRP4 perturbation are consistent with an excitatory neuron-specific role. Thus, LRP4 may not only serve an identifying role at excitatory synapses, but also a functional one. Loss of *lrp4* results in fewer excitatory synapses but has no effect on inhibitory synapses. However, both excitatory and inhibitory neurons show increased synapse number with *lrp4* overexpression ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}--[5](#fig5){ref-type="fig"}). This shared competency suggests that both neurons contain machinery that can be engaged downstream of LRP4 (or the cell surface) to add synapses. Thus, proteins like LRP4 may represent identifiers of excitatory or inhibitory terminals that function by engaging common mechanisms to add synapses.

LRP4 function across evolution {#s3-2}
------------------------------

At the mouse NMJ, LRP4 is the well-established postsynaptic receptor for motoneuron-derived Agrin ([@bib41]; [@bib107], [@bib108]) and regulates synapse formation ([@bib100]) and maintenance ([@bib5]). However, additional roles for LRP4 exist at the level of the presynaptic motoneuron. A retrograde signal composed of LRP4 from the postsynaptic muscle interacts with an unknown receptor in the motoneuron ([@bib106]) to regulate presynaptic differentiation. Thus, at the mouse NMJ, postsynaptic LRP4 has both cell-autonomous and non-cell autonomous roles. In addition, presynaptic LRP4 has been implicated to regulate acetylcholine receptor clustering via MMP-mediated proteolytic cleavage ([@bib102]).

In the mouse CNS, LRP4 regulates synaptic physiology ([@bib27]; [@bib70]), learning and memory, fear conditioning, and CA1 spine density ([@bib27]). Though CNS LRP4 most commonly associates with postsynaptic densities ([@bib90]), it also fractionates with synaptophysin-positive membranes ([@bib27]). Indeed, the observed CNS phenotypes have not been localized to a particular pool of LRP4. Our identification of *Drosophila* LRP4 as a key player in CNS synaptogenesis, however, posits a cell-autonomous presynaptic role. While we cannot rule out an additional, perhaps concurrent, postsynaptic role, our work is the first to demonstrate clear cell-autonomous presynaptic functions for LRP4. Indeed, LRP4 is expressed in PNs and may localize to PN dendrites within the antennal lobe ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In such a case, it could function either presynaptically, at dendrodendritic presynapses ([@bib76]; [@bib92]) or as a postsynaptic factor. Moreover, as the *Drosophila* genome lacks clear Agrin and MuSK homologs, this suggests a synaptic function of LRP4 that evolutionarily precedes Agrin and MuSK recruitment to vertebrate NMJ synaptogenesis.

It remains open whether this presynaptic function is conserved in the mammalian CNS and, if so, what signal LRP4 receives. In *Drosophila*, the signal cannot be Agrin and in the mammalian CNS, Agrin is not essential for CNS synapse formation ([@bib17]). Thus, the Agrin-independence of CNS LRP4 may be conserved across systems. Moreover, our finding that LRP4 promotes excitatory, but not inhibitory, synapse formation and function is consistent with reduced excitatory but normal inhibitory input in hippocampal CA1 neurons of *lrp4* mutant mice ([@bib27]). Moreover, we find that LRP4 in the *Drosophila* CNS functions through the SR-protein kinase SRPK79D. Impaired *srpk79D* function reduces synapse number and overexpression can suppress the functional and morphological defects associated with *lrp4* loss ([Figures 7](#fig7){ref-type="fig"}--[8](#fig8){ref-type="fig"}). This kinase is evolutionarily conserved ([@bib39]) and the three mammalian homologues ([@bib109]) are widely expressed in the mouse brain ([@bib47]), including in the hippocampus. From yeast to human, SRPKs regulate spliceosome assembly and gene expression ([@bib109]) but have not been studied in mammalian synapse formation. It will be interesting to test if these kinases also function in the mammalian CNS. Combined, however, these commonalities suggest a basic conservation between invertebrate and vertebrate systems for future study.

Connecting LRP4 and human disease {#s3-3}
---------------------------------

Recent work implicated LRP4 in both amyotrophic lateral sclerosis (ALS) and myasthenia gravis (MG), two debilitating motor disorders with a worldwide prevalence of \~1/5000. Distinct ALS and MG populations are seropositive for LRP4 autoantibodies ([@bib93]; [@bib95]) and double seronegative for Agrin or MuSK, suggesting that seropositivity is not a byproduct of generalized NMJ breakdown. Further, injection of LRP4 function-blocking antibodies into mice recapitulates MG ([@bib77]). Beyond peripheral symptoms, cognitive impairment (besides that as frontotemporal dementia) also occurs in a subset of ALS patients ([@bib72]). Thus, understanding the roles of LRP4 in the peripheral and central nervous systems has marked clinical significance. Our identification of an evolutionarily conserved kinase, SRPK79D, as a downstream target of LRP4 signaling may offer a window into those roles. As SRPK79D overexpression suppresses the behavioral and the synaptic phenotypes of *lrp4* loss ([Figure 8](#fig8){ref-type="fig"}), if it functions similarly in the mammalian CNS, SRPKs could be a target for therapeutics. Further investigation of how LRP4 functions in the CNS will provide new insight not only into the cognitive aspects of these debilitating motor disorders, but also into the fundamental aspects of excitatory synapse formation.

Materials and methods {#s4}
=====================

Generation of lrp4 CRISPR mutants {#s4-1}
---------------------------------

The *lrp4* mutation was designed following published methods ([@bib30]). Two *lrp4*-specific chimeric RNAs (chiRNA) were cloned into the pU6-BbsI-chiRNA vector as follows - A1, corresponding to an optimal PAM site 2 bp 5' of the start ATG (using primers: 5' CTTCGGCGAGTTTGTGTACATGTC 3' and 5' AAACGACATGTACACAAACTCGCC 3' with a phosphate at the 5' end) and A2, corresponding to an optimal PAM site 34 bp 3' of the TAG stop codon (using primers 5' CTTCGAATCGGTAAATGGTTTCAG 3' and 5' AAACCTGAAACCATTTACCGATTC 3'). Both the A1 and A2 chiRNA plasmids (250 ng / μL) and a pHsp70-Cas9 plasmid (500 ng / μL) were injected into MB03015 embryos (stock BL23835) to produce *lrp4* deletions. MB03015 flies bear a Minos-based Mi{ET1} insertion ([@bib6]) between exons 5 and 6 of the *lrp4* open reading frame; adults with the insertion are marked by expression of a GFP reporter in the eye. Successful events were screened for by the loss of GFP: as the PAM sites were distant from and flanking the insertion, loss of fluorescence likely indicated removal of the intervening sequences (the *lrp4* coding region). Five such lines (representing identical events) were recovered and homozygous viable stocks established: the allele was named *dalek* due to the 'extermination' of the *lrp4* gene, and in homage to the classic villains of 'Doctor Who'. Loss of *lrp4* was assessed using genomic DNA prepared from control and *lrp4^dalek^* adults using the QIAgen DNeasy Blood and Tissue Kit (QIAgen, Valencia, CA). Genomic PCR bands corresponding to exon 2 (534 bp using primers 5' TGTATTCCACGAACCTGGGTATG 3' and 5' CAAAATGCAGCGCCCATTGTT 3') and the exon 7--8 junction (615 bp using primers 5' AGTCTTGATGGTAGCAATAGGCAT 3' and 5' CTCTGGTAGATTTTGACACTG 3') revealed the absence of both regions in *lrp4^dalek^*. The *lrp4^dalek^* deletion was further confirmed by the presence of a 315 bp 'Flank' band (with some background bands present only with the *lrp4^dalek^* deletion) representing the connection of sequences from the 5' and 3' UTRs (amplified by primers 5' AACAGAATCGGAACAGCAGTT 3' and 5' GAGCTTTAACAGGACACGTTT 3') not present in control samples (see [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Finally, antibody staining (see below) revealed the elimination of LRP4 signal in the *lrp4^dalek^* allele, suggesting the creation of a null allele.

Cloning of LRP4 cDNA and transgene construction {#s4-2}
-----------------------------------------------

An adult *Drosophila* cDNA library was made according to manufacturer's protocol using the GeneRacer Kit (ThermoFisher Scientific, Catalog \#L150201, Waltham, MA). From the library, the *lrp4* cDNA was amplified using the forward primer 5' CACCATGTATTTGACAGCCTTT 3' and the reverse primer 5' TGTGATAGTCGAGAGCGT 3' (without the endogenous Stop codon) and cloned directly into the pENTR vector using the pENTR/D-TOPO Cloning Kit (ThermoFisher Scientific, Catalog \#K240020, Waltham, MA). Complete cDNA clones were verified by sequencing. UAS-LRP4-HA was made by recombining pENTR-LRP4 with pUAST-attB-Gateway-3xFLAG-3xHA^29^ via LR clonase. The resultant pUAST-attB-LRP4-3xHA-3xFLAG was transformed into the ΦC31 landing site 86Fb on the 3^rd^ chromosome using standard methods.

Production of LRP4 antibodies {#s4-3}
-----------------------------

Custom antibodies were made by Pierce Custom Services (ThermoFisher, Rockford, IL) against the C-NKRNSRGSSRSVLTFSNPN peptide corresponding to residues 1921--1939 of the intracellular side of LRP4. Rat antisera were Ig-purified and then used at a dilution of 1:200 on adult brains. The specificity of the antibody was verified by the absence of signal in the *lrp4^dalek^* mutant.

Alignment of LRP4 homologues {#s4-4}
----------------------------

The *Drosophila melanogaster* (CG8909; accession AAF48538.1), *Mus musculus* (accession NP_766256.3), and *Homo sapiens* (accession NP_002325.2) LRP4 sequences were obtained from NCBI. CLUSTALW alignment was performed using PSI/T-Coffee for transmembrane proteins (<http://tcoffee.crg.cat/apps/tcoffee/do>:tmcoffee) and expressed graphically using ESPript3.0 (<http://espript.ibcp.fr/ESPript/ESPript/>).

*Drosophila* stocks and transgenic strains {#s4-5}
------------------------------------------

All controls, stocks, and crosses were raised at 25°C. Mutants and transgenes were maintained over balancer chromosomes to enable selection in adult or larval stages. The GMR90B08-GAL4 ([@bib68]) line was used to examine *lrp4* expression (referred to as *lrp4*-GAL4). Four UAS-RNAi lines against differing regions of *lrp4* were also identified: *UAS-lrp4-RNAi 1* (v29900, Vienna Drosophila Resource Center), *UAS-lrp4-RNAi 2* (v108629, Vienna Drosophila Resource Center), *UAS-lrp4-RNAi 3* (JF01570, Harvard TRiP Collection), *UAS-lrp4-RNAi 4* (JF01632, Harvard TRiP Collection). The following GAL4 lines enabled tissue-specific expression: *Or47b-GAL4* (VA1v ORNs) ([@bib97]), *Or67d-GAL4* (DA1 ORNs) ([@bib42]), *Or88a-GAL4* (VA1d ORNs) ([@bib97]), *AM29-GAL4* (DL4 and DM6 ORNs) ([@bib24]), *Mz19-GAL4* (DA1, VA1d, DC3 PNs) ([@bib37]), *Mz699-GAL4* (inhibitory projection neurons that project to the lateral horn) ([@bib43]; [@bib50]), *GAD1-GAL4* (GABAergic inhibitory neurons) ([@bib62]), *pebbled-GAL4* (all ORNs) ([@bib86]). The following UAS transgenic lines were used as either reporters or to alter gene function: UAS-Syt-HA ([@bib74]), *UAS-Brp-Short-mStraw* ([@bib25]), *UAS-DSyd1-GFP* ([@bib66]), *UAS-Dα7-GFP* ([@bib48]), *UAS-mCD8-GFP* ([@bib46]), *UAS-3xHA-mtdT* ([@bib71]), *UAS-FRT-Stop-FRT-mCD8-GFP* ([@bib33]), *UAS-Dcr2* ([@bib23]), *UAS-GABA~B~R2-RNAi* ([@bib75]), *UAS-srpk79D-RNAi* ([@bib39]), *UAS-venus-SRPK79D-\#28* ([@bib39]), *UAS-venus-SRPK79D-\#1A* ([@bib39]). Intersectional analyses were done using the *eyFLP^3.5^* construct ([@bib15]) which expresses FLP in ORNs, but not PNs and *GH146-FLP* ([@bib33]), which expresses in 2/3 of all olfactory PNs but not ORNs. The *srpk79D^atc^* allele ([@bib39]) was used to remove *srpk79D* function.

Immunocytochemistry {#s4-6}
-------------------

Adult brains were dissected at 10 days post eclosion as previously described ([@bib57]; [@bib103]). Third instar larvae were dissected as previously described ([@bib58]). The following primary antibodies were used: mouse antibody to Bruchpilot (1:40, DSHB, Catalog \#mAbnc82, Iowa City, IA) ([@bib44]), rabbit antibody to Synaptotagmin I (1:4000) ([@bib52]), rat antibody to N-Cadherin (1:40, DSHB, Catalog \#mAbDN-EX \#8, Iowa City, IA) ([@bib36]), rat antibody to HA (1:100, Roche, Catalog \#11867423001, Basel, Switzerland), mouse antibody to choline acetyltransferase (ChAT) (1:100, DSHB, Catalog \#mAbChAT4B1, Iowa City, IA) ([@bib87]), mouse antibody to ELAV (DSHB, mAb9F8A9, 1:100) ([@bib64]), rabbit antibody to GABA (1:200, Sigma-Aldrich, Catalog \#A2052, St. Louis, MO), mouse antibody to Repo (1:100, DSHB, Catalog \#mAb8D12, Iowa City, IA) ([@bib2]), rabbit antibody to vGlut (1:500) ([@bib18]), rabbit antibody to dsRed (1:250, Clontech, Catalog \#632496, Mountain View, CA), chicken antibody to GFP (1:1000, Aves Labs, Catalog \#GFP-1020, Tigard, OR), Alexa647-conjugated goat antibody to HRP (1:100, Jackson ImmunoResearch, Catalog \#123-605-021, West Grove, PA). Alexa488-, Alexa568-, and Alexa647-conjugated secondary antibodies were used at 1:250 (ThermoFisher Scientific and Jackson ImmunoResearch, Various Catalog \#s). CF633-conjugated secondary antibodies were used at 1:250 (Biotium). FITC-conjugated secondary antibodies were used at 1:200 (Jackson ImmunoResearch, Catalog \#703-095-155, West Grove, PA).

Proximity ligation assay {#s4-7}
------------------------

Brains were processed as described and stained using rabbit anti-GFP antibodies at 1:500 (ThermoFisher Scientific, Catalog \#A-11122, Waltham, MA) with FITC-conjugated secondary antibodies and mouse anti-HA antibodies at 1:250 (Sigma-Aldrich, Catalog \#A2095, St. Louis, MO) with Alexa647-conjugated secondary antibodies, leaving the red channel open. For PLA, we used the DuoLink Mouse Rabbit in situ PLA kit (Sigma-Aldrich, Catalog \#DUO92101, St. Louis, MO). Following the last wash after secondary antibody incubation, the brains were incubated in the anti-mouse and / or anti-rabbit PLA probes at a 1:5 dilution for 2 hr at 37°C. Brains were then washed thrice for 10' each with Wash Buffer A, and incubated in Ligation solution (1:40 ligase in ligation buffer) for 1 hr at 37°C. Brains were washed in Wash buffer A for three times at 10' each and then incubated in Amplification solution (1:80 dilution of polymerase in Amplification buffer) for 2 hr at 37°C. Finally, brains were washed three times for 10' each in Wash Buffer B, and incubated in SlowFade overnight before mounting. Controls without Probes went through the identical process as those with probes, but with water substituted for the probes themselves in the first PLA step. Brains were imaged as described via confocal microscopy.

Imaging, synaptic quantification and image processing {#s4-8}
-----------------------------------------------------

All images were obtained using a Zeiss LSM510 Meta laser-scanning confocal microscope (Carl Zeiss, Oberkochen, Germany) using either a 40 × 1.4 NA PlanApo or a 63 × 1.4 NA PlanApo lens. Images of synaptic puncta (Brp-Short-mStraw or Dα7-GFP) and neurite membrane (mCD8-GFP, 3xHA-mTDT) were imaged, processed and quantified as previously described ([@bib57]) with the following adjustments: images of synaptic puncta in the lateral horn (Mz19-GAL4, Mz699-GAL4, [Figure 5](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) were imaged at 63X, with an optical zoom of 2. Mz19 and Mz699 images were processed with a spot size of 0.6 µm and neurite volume calculated with a smoothing of 0.2 µm and a local contrast of 0.5 µm.

Images were processed and figures prepared using Adobe Photoshop CS4 and Adobe Illustrator CS4 (Adobe Systems, San Jose, CA). For antibody staining comparisons between genotypes, samples were imaged and processed under identical conditions. Fluorescence intensity was measured with ImageJ (NIH, Bethesda, MD).

Electron microscopy {#s4-9}
-------------------

Transmission electron microscopy was performed on 10 day old adult control and *lrp4^dalek^* male brains as previously described ([@bib57]). Putative ORN terminals were identified based on morphology ([@bib76]; [@bib92]) and quantified as described ([@bib57]). Terminal perimeter was measured using ImageJ (NIH, Bethesda, MD) and used to calculate T-bar density. All quantification was done with the user blind to the genotype.

Expansion microscopy {#s4-10}
--------------------

Protein retention expansion microscopy ([@bib91]) was modified for use with *Drosophila* brain tissue. Fixed and antibody-labeled brains were treated with 100 μg / mL acryloyl-X, SE (ThermoFisher Scientific, Catalog \#A20770, Waltham, MA) overnight at room temperature and then embedded in polyelectrolyte gel for two hours at 37**°**C. Slices containing brains were excised from solidified polyelectrolyte gel and immersed in digestion buffer with 200 μg / mL Proteinase K (ThermoFisher Scientific, Catalog \#AM2546, Waltham, MA) overnight at room temperature. Slices achieved maximum expansion after five washes with deionized water. Fully expanded gel slices were anchored to the bottom of a petri dish with 2% low melting point agarose. Confocal microscopy images were obtained on a Leica SP8 with a 25x water immersion objective (Leica Microsystems, Wetzlar Germany).

Statistical analysis {#s4-11}
--------------------

Statistical analysis was completed using Prism 6.07 (GraphPad Software, Inc., La Jolla, CA). For representative datasets, the experimenter was blind to genotype during quantification and data analysis. Significance between two samples was determined using student's t-test. Significance amongst multiple samples was determined using one-way ANOVA with a Tukey's post-test to correct for multiple comparisons. Significance between two samples (for EM) was determined using a two-tailed student's t-test.

Behavioral analyses {#s4-12}
-------------------

Olfactory trap assays were constructed as described ([@bib71]). Flies were raised in a 12/12 light/dark incubator. For each cohort, 25 flies of the appropriate genotype were starved overnight in a 1% agar vial in complete darkness. They were anesthetized briefly on ice and transferred to the olfactory trap, which contained an experimental vial of apple cider vinegar (ACV: Safeway, Palo Alto, CA) and a control vial of water. Flies were then left in the trap for 16 hr in complete darkness before being quantified. Preference index was calculated as (Flies~ACV~ -- Flies~Water~) / Flies~Total~.

Genotypes {#s4-13}
---------

See [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for a listing of complete genotypes by figure panel.
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Thank you for submitting your article \"Presynaptic LRP4 Promotes Synapse Number and Function of Excitatory CNS Neurons\" for consideration by *eLife*. Your article has been favorably evaluated two reviewers, one of whom, K VijayRaghavan (Senior Editor), is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal their identity: Rachel Wilson (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. As you can see the comments are readily addressable. We look forward to a revised manuscript which will be speedily accepted.

*Reviewer \#1:*

This is an impressive study of the molecular organizers of presynaptic neurotransmitter release sites. This study uses a remarkably wide range of experimental approaches that beautifully exploit the *Drosophila* genetic toolkit. Mosca et al. begin by identifying the *Drosophila* homolog of LRP4. LRP4 has well-documented roles at mammalian neuromuscular junctions as a postsynaptic receptor organizer (and agrin receptor), and it clearly has roles at mammalian CNS synapses also, but its CNS roles are relatively poorly understood. Here, Mosca et al. show that it LRP4 clearly localizes to a specific subset of presynaptic neurotransmitter release sites in the *Drosophila* brain, and it is essential for the proper organization of presynaptic machinery at those sites. They show that loss of LRP4 reduces synapse number, whereas overexpression increases synapse number. Finally, they go on to show that LRP4 functions via the serine-arginine protein kinase SRPK79D, and LRP4 is required to maintain the proper localization of SRPK79D at presynaptic sites. The choice of experimental techniques consistently aims for the highest technical standard, and the data are of high technical quality. This study sheds new light on the mysterious CNS roles of a well-known NMJ synaptic organizer, and it sets a high standard for future work using *Drosophila* as a model organism in this field.

1\) I do not think it is valid to conclude that \"LRP4 preferentially localizes to *excitatory* neuron terminals\", although I suppose this depends on the definition of \"preferentially\". [Figure 1](#fig1){ref-type="fig"} shows that 59% of LRP+ somata in the vicinity of the antennal lobe are cholinergic, while 22% are glutamatergic, and essentially 0 are GABAergic. But there is solid evidence that glutamate inhibits antennal lobe neurons, and when inhibitory glutatamate-gated chloride channels are removed from these neurons, there is no physiological evidence of any residual excitation evoked by glutamate (Liu et al., 2013, [Figure 3](#fig3){ref-type="fig"}). Some of the somata in the vicinity of the antennal lobe might arborize in other neuropils (outside the antennal lobe) where glutamate has an excitatory role, but that is pure speculation at this point. We just don\'t know whether the LRP+ glutamatergic neurons are excitatory or inhibitory. Therefore, I would be hesitant to conclude that LRP preferentially localizes to excitatory terminals. Instead, it seems more accurate to say that LRP is expressed by a subset of cholinergic (excitatory) neurons and also a subset of glutamatergic neurons that might be excitatory or inhibitory. That said, the expression pattern of LRP is strikingly selective: it is excluded from GABAergic neurons.

2\) The phenotypes associated with the *lrp4^dale^k* mutation are attributed to the authors to LRP\'s presynaptic roles: e.g., the authors write that \"presynaptic LRP4 loss reduces synapse number as assayed both pre- and postsynaptically\". Clearly, LRP does have presynaptic roles, given the antennal lobe phenotypes associated with ORN-specific perturbation, and also the lateral horn phenotypes associated with PN-specific perturbation. However, I don\'t see a good reason to exclude a postsynaptic role for LRP4. LRP4 is expressed by PNs, and we might expect it to traffic to PN dendrites, given that PN dendrites release neurotransmitter (Ng et al., 2002) and contain T-bars (Rybak et al., 2016; Tobin et al., 2017). It is possible that LRP4 is excluded from PN dendrites, and it functions in PN axons only. Alternatively, it is possible that LRP4 has a role in organizing neurotransmitter release sites in PN dendrites, but it has no role as a postsynaptic organizer in PN dendrites. Finally, the third alternative is that LRP4 plays a role in organizing postsynaptic sites in PN dendrites, potentially in addition to organizing presynaptic sites in presynaptic dendrites. A postsynaptic role for LRP4 in the Drosophlia brain is not implausible, given its well-documented role in organizing postsynaptic sites in mammalian muscle. I do not think the authors need to perform new experiments to address this issue. However, if they already have data on hand which could discriminate between these three alternatives, they should show it. And if they don\'t, then they should explicitly discuss the possibility that the phenotypes associated with the *lrp4^dalek^* mutation could reflect roles for postsynaptic LRP4 as well as presynaptic LRP4.

*Reviewer \#2:*

The authors study LRP4, previously well studied in post-synaptic systems in the neuromuscular junction in mice. Here, they show that LRP4 has important presynaptic functions in the fly brain. They start by showing that LRP4 localises to neuron terminals at or near active zones. They say that this localization is preferential to excitatory terminals. It is striking that there is no localization to some inhibitory terminals. But, whether the localization seen is specific to excitatory terminals only is not fully proven by experiments. The authors may want to temper this conclusion.

The authors then examine the loss of function of presynaptic LRP4. This results in the reduction of synapse number, specific to excitatory synapses. When they examine olfactory behaviour after loss of function in ORN they remarkably find that \"A complete loss of olfactory attraction was unexpected for a manipulation that reduced synapse number by \~30%.\" This is an interesting and unexpected result and they hypothesise that inhibition of inhibitory receptors should rescue this phenotype and this is tested elegantly. Gain-of function experiments have the expected \'opposite effect\', but in both excitatory and inhibitory neurons. Learning from the fly NMJ the and the \"similarity in the transverse nerve phenotypes and the role of SRPK79D at peripheral synapses, we hypothesised that LRP4 and SRPK79D could operate together in the CNS to regulate synapse number.\" They test the role of SRPK79D and find that it requires LRP4 and show that they interact proximity ligation assays.

In summary, this is an important study, very thorough, and whose results are a significant scientific advance for a general audience.

10.7554/eLife.27347.023

Author response

*Reviewer \#1:*

*\[...\] 1) I do not think it is valid to conclude that \"LRP4 preferentially localizes to excitatory neuron terminals\", although I suppose this depends on the definition of \"preferentially\". [Figure 1](#fig1){ref-type="fig"} shows that 59% of LRP+ somata in the vicinity of the antennal lobe are cholinergic, while 22% are glutamatergic, and essentially 0 are GABAergic. But there is solid evidence that glutamate inhibits antennal lobe neurons, and when inhibitory glutatamate-gated chloride channels are removed from these neurons, there is no physiological evidence of any residual excitation evoked by glutamate (Liu et al., 2013, [Figure 3](#fig3){ref-type="fig"}). Some of the somata in the vicinity of the antennal lobe might arborize in other neuropils (outside the antennal lobe) where glutamate has an excitatory role, but that is pure speculation at this point. We just don\'t know whether the LRP+ glutamatergic neurons are excitatory or inhibitory. Therefore, I would be hesitant to conclude that LRP preferentially localizes to excitatory terminals. Instead, it seems more accurate to say that LRP is expressed by a subset of cholinergic (excitatory) neurons and also a subset of glutamatergic neurons that might be excitatory or inhibitory. That said, the expression pattern of LRP is strikingly selective: it is excluded from GABAergic neurons.*

We agree with the reviewers' caveats to our statement regarding the preferential localization of LRP4 to excitatory terminals. Therefore, we have adjusted the language in appropriate sections to highlight three major points: 1) the striking exclusion of LRP4 from GABAergic neurons, 2) the cholinergic excitatory identity of a majority of LRP4+ cells, and 3) the fact that our data cannot completely rule out that the subset of LRP4+ neurons are inhibitory. See Abstract; subsection "LRP4 is a synaptic protein expressed in excitatory neurons", last paragraph; Discussion, first paragraph and subsection "LRP4 as a synaptic regulator that distinguishes excitatory from inhibitory presynaptic terminals", last paragraph, for specific changes.

*2) The phenotypes associated with the lrp4^dale^k mutation are attributed to the authors to LRP\'s presynaptic roles: e.g., the authors write that \"presynaptic LRP4 loss reduces synapse number as assayed both pre- and postsynaptically\". Clearly, LRP does have presynaptic roles, given the antennal lobe phenotypes associated with ORN-specific perturbation, and also the lateral horn phenotypes associated with PN-specific perturbation. However, I don\'t see a good reason to exclude a postsynaptic role for LRP4. LRP4 is expressed by PNs, and we might expect it to traffic to PN dendrites, given that PN dendrites release neurotransmitter (Ng et al., 2002) and contain T-bars (Rybak et al., 2016; Tobin et al., 2017). It is possible that LRP4 is excluded from PN dendrites, and it functions in PN axons only. Alternatively, it is possible that LRP4 has a role in organizing neurotransmitter release sites in PN dendrites, but it has no role as a postsynaptic organizer in PN dendrites. Finally, the third alternative is that LRP4 plays a role in organizing postsynaptic sites in PN dendrites, potentially in addition to organizing presynaptic sites in presynaptic dendrites. A postsynaptic role for LRP4 in the Drosophlia brain is not implausible, given its well-documented role in organizing postsynaptic sites in mammalian muscle. I do not think the authors need to perform new experiments to address this issue. However, if they already have data on hand which could discriminate between these three alternatives, they should show it. And if they don\'t, then they should explicitly discuss the possibility that the phenotypes associated with the lrp4^dalek^ mutation could reflect roles for postsynaptic LRP4 as well as presynaptic LRP4.*

Indeed, this is correct. We cannot rule out a postsynaptic role for LRP4, nor is it our intent to do so! Rather, we focus on the presynaptic role for this organizer. It is unlikely that LRP4 is excluded from PN dendrites as there is robust LRP4-HA localization in the region of PN dendrites when expressed via *lrp4-GAL4* ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In fact, we hypothesize that the second alternative posted by the reviewer is correct: that any LRP4 localizing to PN dendrites may serve a role as a presynaptic organizer for dendrodendritic synapses that reside there. Finally, the possibility of LRP4 as a postsynaptic protein remains present. Though we did not observe phenotypes consistent with that interpretation with PN-specific RNAi, it is difficult to conclusively interpret negative data. To acknowledge and discuss these alternative interpretations, we have adjusted the Results and Discussion sections where appropriate. See subsection "Perturbing presynaptic LRP4 changes ORN synapse number", bottom of third paragraph and subsection "LRP4 function across evolution", second paragraph, for specific changes.

*Reviewer \#2:*

*The authors study LRP4, previously well studied in post-synaptic systems in the neuromuscular junction in mice. Here, they show that LRP4 has important presynaptic functions in the fly brain. They start by showing that LRP4 localises to neuron terminals at or near active zones. They say that this localization is preferential to excitatory terminals. It is striking that there is no localization to some inhibitory terminals. But, whether the localization seen is specific to excitatory terminals only is not fully proven by experiments. The authors may want to temper this conclusion.*

The reviewer raises a valid point; we have altered the language of our assertions (as above) to highlight alternative possibilities. As for reviewer 1, please see Abstract), subsection "LRP4 is a synaptic protein expressed in excitatory neurons", last paragraph, Discussion, first paragraph) and subsection "LRP4 as a synaptic regulator that distinguishes excitatory from inhibitory presynaptic terminals", last paragraph, for specific changes.
